| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.2 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.39 | 0.2 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |